1. Home
  2. QBTS vs GKOS Comparison

QBTS vs GKOS Comparison

Compare QBTS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QBTS
  • GKOS
  • Stock Information
  • Founded
  • QBTS 1999
  • GKOS 1998
  • Country
  • QBTS United States
  • GKOS United States
  • Employees
  • QBTS N/A
  • GKOS N/A
  • Industry
  • QBTS Retail: Computer Software & Peripheral Equipment
  • GKOS Medical/Dental Instruments
  • Sector
  • QBTS Technology
  • GKOS Health Care
  • Exchange
  • QBTS Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • QBTS 5.3B
  • GKOS 5.8B
  • IPO Year
  • QBTS N/A
  • GKOS 2015
  • Fundamental
  • Price
  • QBTS $16.88
  • GKOS $84.66
  • Analyst Decision
  • QBTS Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • QBTS 10
  • GKOS 12
  • Target Price
  • QBTS $19.40
  • GKOS $131.17
  • AVG Volume (30 Days)
  • QBTS 47.9M
  • GKOS 1.3M
  • Earning Date
  • QBTS 08-07-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • QBTS N/A
  • GKOS N/A
  • EPS Growth
  • QBTS N/A
  • GKOS N/A
  • EPS
  • QBTS N/A
  • GKOS N/A
  • Revenue
  • QBTS $22,275,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • QBTS $180.44
  • GKOS $27.88
  • Revenue Next Year
  • QBTS $56.52
  • GKOS $27.76
  • P/E Ratio
  • QBTS N/A
  • GKOS N/A
  • Revenue Growth
  • QBTS 120.20
  • GKOS 26.70
  • 52 Week Low
  • QBTS $0.75
  • GKOS $77.10
  • 52 Week High
  • QBTS $20.56
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • QBTS 48.52
  • GKOS 27.48
  • Support Level
  • QBTS $16.56
  • GKOS $84.58
  • Resistance Level
  • QBTS $19.17
  • GKOS $90.30
  • Average True Range (ATR)
  • QBTS 1.42
  • GKOS 3.59
  • MACD
  • QBTS -0.22
  • GKOS -0.85
  • Stochastic Oscillator
  • QBTS 17.67
  • GKOS 11.61

About QBTS D-Wave Quantum Inc.

D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: